Shares of TYRA are trading -16% lower today - on the back of strong news

Shares of Tyra Biosciences Inc (TYRA) are trading -16% lower at a price of $8.44 at the time of this writing. The stock is moving sinking faster than peers on a somewhat glum day for the Health Care sector.

Recent happenings:
1. Tyra Biosciences reported a GAAP EPS of -$0.36 for the second quarter of 2022.
2. The company received IND clearance from FDA to proceed with SURF301 Study of TYRA-300.
3. As of Q2 2022, Tyra Biosciences was well-capitalized with cash and cash equivalents of $275.1 million.

Tyra Biosciences Inc has been trading between a 52-week high of $31.36 and a 52-week low of $4.93. The stock has a market cap of $352 Million.

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra is using its proprietary SNÅP platform, which is optimized to enable rapid and precise refinement of structural design through iterative molecular SNÅPshots, in order to generate next-generation product candidates that are specifically designed to address acquired drug resistance and provide alternative treatment options.